Clinical Trial Update: Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the long-term efficacy of iguratimod, alone or in combination with methotrexate, in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Iguratimod (iguratimod)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN